Voyager Therapeutics (VYGR) Construction in Progress (2016)
Voyager Therapeutics' (VYGR) quarterly Construction in Progress came in at $3.0 million in Q4 2016.
Powered by 
Analysis
Voyager Therapeutics (VYGR) Construction in Progress (2016) Analysis & Trends
Voyager Therapeutics has disclosed Construction in Progress across 1 years of filings, most recently posting $3.0 million for Q4 2016.
- In Q4 2016, Construction in Progress changed N/A year-over-year to $3.0 million; the TTM figure through Dec 2016 stood at $3.0 million (changed N/A YoY), while the FY2016 annual figure was $3.0 million, changed N/A from the prior year.
- Construction in Progress came in at $3.0 million for Q4 2016 at Voyager Therapeutics.
- In the past five years, Construction in Progress ranged from a high of $3.0 million in Q4 2016 to a low of $3.0 million in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.23 Bn | 9.39 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.71 Bn | 3.42 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.57 Bn | 2.60 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 328,000.00 |
| 8 | Sarepta Therapeutics | 2.20 Bn | 1.41 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn | - |
| 10 | Voyager Therapeutics | 191.94 Mn | 75.60 Mn | - | - |